Despite these challenges, Netrin-1 consistently suppresses proinflammatory mediators, including TNF-α, IL-6, and NF-κB, albeit through distinct pathways such as PPARγ in SAH and AKT in MS. Here, NFKB1 is linked to myeloid sarcoma.